Tirzepatide 30mg

Tirzepatide is a synthetic dual GIP/GLP-1 receptor agonist — one of the most closely watched compound classes in current metabolic research. By acting on both the glucose-dependent insulinotropic polypeptide receptor (GIPR) and the glucagon-like peptide-1 receptor (GLP-1R), it engages two distinct incretin pathways simultaneously, and has been the subject of extensive research examining energy intake, insulin sensitivity, and adipose tissue metabolism. This listing is for the 30mg concentration.

Every batch is independently third-party tested for HPLC purity (≥99%), molecular mass, and bacterial endotoxins. This batch (CSX-TR30-0626) tested at 99.98% purity — full results are published on our Lab Results page and matched to your vial’s batch number.

For in-vitro laboratory research use only. Not for human or veterinary use, consumption, injection, or therapeutic application.